EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

Item
http://www.wikidata.org/entity/Q43256499
Molecular testing to optimize therapeutic decision making in advanced colorectal cancerERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysisXELOX in colorectal cancer: a convenient option for the future?Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.A meta-analysis identifies ERCC1 gene polymorphism as a predictor of better patient response to treatment with radiochemotherapy.Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
P2860

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

Item
http://www.wikidata.org/entity/Q43256499
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@en
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@nl
type
label
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@en
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@nl
prefLabel
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@en
EGF61A>G polymorphism as predi ...... metastatic colorectal cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
EGF61A>G polymorphism as predi ...... n metastatic colorectal cancer
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921